Bayer Recalls Alka-Seltzer due to Potential Allergic Reaction

Comments (0)

Bayer recently announced a recall of all Alka-Seltzer Plus packages that were sold at select stores after February 9, 2018. The stores include Walmart, CVS, Walgreens, and Kroger. The boxes that are included in the recall include those with the Bayer logo with an orange or a green background. The boxes are being recalled because the ingredients on the box may not match the actual products in the carton. Alka-Seltzer Plus is intended to temporarily relieve symptoms associated with cold and flu, such as cough, fever, congestion, and mucus.

Because the ingredients on the package may not match the ingredients in the medication in the carton, consumers could ingest a product they aren’t expecting. This could lead to an allergic or anaphylactic reaction. They could end up consuming a product which could harm their medical condition or that they want to avoid for other reasons.

Bayer is notifying retailers electronically and by certified mail of the recalls and is arranging for returns. Consumers who purchased packages of Alka-Seltzer Plus that are being recalled should stop using the product and contact Bayer for a refund or with questions. Fortunately, thus far no complaints have been made that the medication has resulted in adverse health consequences.

It’s critical that drug manufacturers manufacture products which are safe for consumption. In many cases, a drug company may learn of a danger with their product but may hide those dangers, particularly if the drug is a profitable one. If a drug company fails to make products that are safe for the general public, that drug company can be sued for damages.

If you have been harmed by a dangerous prescription drug, call the prescription drug recall attorneys at Kennedy Hodges at 855-947-0707, or visit us on our YouTube channel to learn more about the firm.
Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."


Email:* (will not be published)


Notify me of follow-up comments via email.